Elda Righi received her BSc in Medicine and Surgery from the University of Genoa in 2002, with a Specialization in Infectious Diseases from the University of Genoa and San Martino University Hospital in 2006, and her Ph.D. in Basic and Experimental Immunology from the University of Genoa, in association with the VIC Center at Massachusetts General Hospital, Boston US, in 2011. Currently, she is an Associate Professor at the Department of Diagnostic and Public Health, University of Verona, Italy. She has been working on resistant infections and immunocompromised patients since 2011 and on COVID-19, including its long-term effects and microbiome, since 2020. She has published over 140 articles, reviews, and book chapters as author/coauthor.
Anna Gorska is a Postdoctoral Researcher in Infectious Diseases at the University of Verona, Italy. She received her B.Sc. degree in Macro-field of Study, Bioinformatics and Systems Biology, at the University of Warsaw, Poland, in 2011, completed her Master’s studies at the University of Warsaw in 2013, and earned her Ph.D. at the Center for Bioinformatics, Faculty of Science, University of Tübingen, Germany, in 2019. She is currently managing and involved in several interdisciplinary tasks within the EU-funded Orchestra project focusing on post-COVID condition. The tasks include clinical, genomic and meta genomic data analysis, and scientific data visualization. The other part of her work is within the Value-Dx project, with tasks dedicated to developing clinical algorithms to guide the diagnosis of the respiratory tract infections and prevent inadequate antibiotic prescribing.
Massimo Mirandola has extensive experience in the area of public health, with a particular focus on epidemiological research in the field of HIV and STI prevention. For more than 20 years, he has worked in the area of population surveys with a special focus on bio-behavioural surveys among vulnerable populations. He is specialized in the techniques of project management in the provision of healthcare and
social services. Throughout his career, in this capacity as both a scientist and a manager, he has had
public appointments both in academic institutions as well as with national and international research bodies. He currently is a Temporary Professor at the Infectious Diseases Section of the Department of Public Health and Diagnostics (Verona University Hospital). He is also a member of the WHO Advisory Group on STI POCTs.
Evelina Tacconelli is a Full Professor of Infectious Diseases at the University of Verona, Italy and Head of the DZIF Clinical Research Unit on healthcare associated infections and antimicrobial resistance at the Tübingen University, Germany. She has been Lecturer on Medicine at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA. She was recipient of award from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for research excellence. Consultant for WHO, ECDC and EMA on antimicrobial resistance and infection control. Her main areas of scientific interest are epidemiology, clinical and therapeutic aspects of healthcare-associated infections and preventive measures aimed to reduce the spreading of antibiotic-resistant bacteria. She is the ESCMID Guideline Officer for Infectious Diseases and Clinical Microbiology. Chair of the European Committee of Infection Control (EUCIC). Involved (partner site or coordinator) in many European studies on prevention and therapy of infections caused by antibiotic-resistant bacteria financed by European Commission, WHO, JPI-AMR, Horizon2020, DG-Sanco, IMI, and DZIF.
Assunta Sartor is director of the Microbiology Unit at the Azienda Sanitaria Universitaria Friuli Centrale (ASU FC). She has a degree in Medicine and is specialised in Microbiology and Infectious Diseases. Her interests include Antimicrobial Resistance; Gram-Negative bacteria; and automated systems for resistance detection.
